Related Articles
RELB: A novel prognostic marker for glioblastoma as identified by population‑based analysis
Prognostic biomarker HIF1α and its correlation with immune infiltration in gliomas
Thrombospondin‑1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma Corrigendum in /10.3892/or.2022.8473
Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma